BIOMAT Database Logo BIOMAT Database Logo

Acute paronychia after high-dose methotrexate therapy. 1983

G L Wantzin, and K Thomsen

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D010304 Paronychia An inflammatory reaction involving the folds of the skin surrounding the fingernail. It is characterized by acute or chronic purulent, tender, and painful swellings of the tissues around the nail, caused by an abscess of the nail fold. The pathogenic yeast causing paronychia is most frequently Candida albicans. Saprophytic fungi may also be involved. The causative bacteria are usually Staphylococcus, Pseudomonas aeruginosa, or Streptococcus. (Andrews' Diseases of the Skin, 8th ed, p271) Paronychias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G L Wantzin, and K Thomsen
[(Management of acute toxicity after high dose methotrexate therapy)].
December 1979, Onkologie,
G L Wantzin, and K Thomsen
Ferrokinetics after high-dose methotrexate therapy.
October 1981, Klinische Wochenschrift,
G L Wantzin, and K Thomsen
Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy.
January 1985, Cancer chemotherapy and pharmacology,
G L Wantzin, and K Thomsen
High-dose methotrexate therapy.
February 1977, The Medical journal of Australia,
G L Wantzin, and K Thomsen
Methotrexate and methotrexate polyglutamates in human sarcoma metastases after high-dose methotrexate therapy.
November 1983, Klinische Wochenschrift,
G L Wantzin, and K Thomsen
Acute renal failure after high-dose methotrexate therapy in a patient with ileostomy.
November 2009, [Rinsho ketsueki] The Japanese journal of clinical hematology,
G L Wantzin, and K Thomsen
Acute urticaria and hepatitis complicating high-dose methotrexate therapy.
February 1995, Medical and pediatric oncology,
G L Wantzin, and K Thomsen
Acute hepatotoxicity after high-dose methotrexate administration to rats.
August 1991, Pharmacology & toxicology,
G L Wantzin, and K Thomsen
Acute renal failure after high-dose methotrexate therapy. Role of hemodialysis and plasma exchange in methotrexate removal.
January 1989, Nephron,
G L Wantzin, and K Thomsen
[Overexposure to methotrexate after high-dose therapy; salvage measures].
September 1991, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!